Don’t miss the latest developments in business and finance.

Alembic Pharmaceuticals receives ANDA approval for Amantadine Hydrochloride Capsules

Image
Capital Market
Last Updated : Jun 22 2017 | 9:47 AM IST

From USFDA

Alembic Pharmaceuticals has received approval from USFDA for its ANDA for Amantadine Hydrochloride Capsules, USP, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Symmetrel Capsules, 100 mg of Endo Pharmaceuticals Inc.

Powered by Capital Market - Live News

Also Read

First Published: Jun 22 2017 | 9:28 AM IST

Next Story